fbpx

AdlensFocuss set for June Debut

Adlens® introduced its Variable Power Optics (VPOTM) eyewear, AdlensFocuss™ at Vison Expo East.

The new product’s  precision vision on demand is achieved by turning a dial. The dial is hidden within a more fashion-forward frame than prior versions of Adlens products, significantly improving the aesthetics. The VPO system, which changes the lens power, is invisibly enclosed as an adjustable membrane within the lenses.  According to the company’s press release, the patented technology provides 4x more viewing area at near, intermediate and distance than the best freeform progressive lenses.

Tested with eye care patients through a 4-month trial with LensCrafters in USA, Adlens validated the technology and aims to take 3-5% of the progressive lens market. 88% of customers in the trial  stated they would purchase another pair as their next eyewear, while 96% commented that overall vision with AdlensFocuss was good, great, or perfect.

David Eichelberger, Senior Vice President at Adlens, commented, “We couldn’t be happier that eye care patients have responded to our technology just as we expected and in many cases, even better than that. We’re all about learning from the patient, and want to keep developing the experience for customers and ECPs as AdlensFocuss goes out through this first wave.”

AdlensFocuss will be available to a select 150 eye care professionals in the US. After training, delivery of product to patients will begin in June. Adlens executives told VuePoint that UK will follow the as the priority launch country after US and thereafter other markets including Canada. The Canadian market can expect to see Focuss in 2016. Significant investments in capacity are being made at their Oxford UK facility  in 2015 to meet the anticipated global demand.

Co-founded in 2005 in Oxford, by businessman and philanthropist James Chen, Adlens is the global leader in adjustable focus eyewear.

Featured Posts

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read More

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read More

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read More

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read More

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more